Originally published by our sister publication Pharmacy Practice News
Correcting the harms of malnutrition in inflammatory bowel disease often leads to better response to biologic therapies and shorter hospital stays, so physicians should screen every IBD patient for malnutrition risk and conduct a more rigorous assessment on anyone identified as high risk, according to speakers at the 2024 annual meeting of the American Society for Parenteral and Enteral